Robotic early indicator system for pharmaceutical and biotechnology applications, measuring the permeation of drug compounds from the human digestive system into the blood stream
Sirius Analytical Instruments announces the exclusive distribution rights for Europe of the Pampa Evolution by Pion. The Pampa Evolution (parallel artificial membrane permeability analysis) is a new in vitro automated product used for measuring drug permeability and membrane retention.
The Pampa Evolution is a robotic based early indicator system ideal for pharmaceutical and biotechnology applications, measuring the permeation of drug compounds from the human digestive system into the blood stream. PAMPA Evolution is concerned with measuring high throughput, permeability through a wide variety of artificial membrane systems.
Pampa Evolution delivers the next generation of high-throughput permeability assessment and analytical algorithms for permeability and membrane retention calculations.
This is possible through an integrated 96-well plate UV spectrophotometer or off-line using LC/MS.
The practical UV range is 250-500nm with DMSO solutions, which are introduced as 10-30mM.
198 assays can be throughput in 24 hours at low cost with simple results processing.
